UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selective Expression of Interleukin 10, Interferon γ, and Granulocyte-Macrophage Colony-Stimulating Factor in Ovarian Cancer Biopsies

Proceedings of the National Academy of Sciences - PNAS, 1992-08, Vol.89 (16), p.7708-7712

1992

Volltextzugriff (PDF)

Anemia and quality of life including anemia-related symptoms in patients with solid tumors in clinical practice

Medical oncology (Northwood, London, England), 2007-01, Vol.24 (1), p.95-102

2007

Volltextzugriff (PDF)

Identification of New HER2/neu-Derived Peptide Epitopes That Can Elicit Specific CTL Against Autologous and Allogeneic Carcinomas and Melanomas

The Journal of immunology (1950), 1999-07, Vol.163 (2), p.1037-1044

1999

Volltextzugriff (PDF)

ASSOCIATION BETWEEN EXPRESSION OF HLA-A2 AND OVARIAN CANCER

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.52-52

2004

Volltextzugriff (PDF)

An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital

Journal of oncology pharmacy practice, 2006-06, Vol.12 (2), p.75-81

2006

Volltextzugriff (PDF)

High frequency of human leucocyte antigen (HLA) A2 reflects a poorer prognosis in a group of advanced ovarian cancer patients

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.5054-5054

2005

Volltextzugriff (PDF)

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates

Medical oncology (Northwood, London, England), 2004-01, Vol.21 (1), p.49-52

2004

Volltextzugriff (PDF)

Mechanisms of escape from CD8+ T‐cell clones specific for the HER‐2/NEU proto‐oncogene expressed in ovarian carcinomas: Related and unrelated to decreased MHC class 1 expression

International journal of cancer, 1997-01, Vol.70 (1), p.112-119

1997

Volltextzugriff (PDF)

Clinical relevance of the CA 125 assay in monitoring of ovarian cancer patients

American journal of clinical oncology, 1991-04, Vol.14 (2), p.111-114

1991

Volltextzugriff (PDF)

Human ex vivo carcinoma cells produce transforming growth factor β and thereby can inhibit lymphocyte functions in vitro

Cancer Immunology, Immunotherapy, 1997-01, Vol.43 (6), p.317-323

1997

Volltextzugriff (PDF)

Molecular analysis of the retinoblastoma gene in primary ovarian cancer cells

International journal of cancer, 1994-09, Vol.58 (5), p.663-667

1994

Volltextzugriff (PDF)

Human leukocyte antigen (HLA) a2 as a negative prognostic factor in ovarian cancer patients

EJC SUPPLEMENTS, 2005, Vol.3 (2), p.265

2005

Volltextzugriff (PDF)

High frequency of human leucocyte antigen (HLA) A2 reflects a poorer prognosis in a group of advanced ovarian cancer patients

JOURNAL OF CLINICAL ONCOLOGY, 2005, Vol.23 (16), p.467S

2005

Volltextzugriff (PDF)

Mechanisms of escape from CD8+ T-cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: related and unrelated to decreased MHC class 1 expression

International journal of cancer, 1997, Vol.70 (1), p.112

1997

Volltextzugriff (PDF)

Mechanisms of escape from CD8 super(+) T-cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: Related and unrelated to decreased MHC class 1 expression

International journal of cancer, 1997-01, Vol.70 (1), p.112-119

1997

Volltextzugriff (PDF)

Interferon-gamma and tumor necrosis factor-alpha treatment of ex vivo human carcinoma cells potentiates their interaction with allogeneic lymphocytes

Journal of interferon & cytokine research, 1996-03, Vol.16 (3), p.201-207

1996

Volltextzugriff (PDF)

Restricted T cell receptor V-β and J-β usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas

Cancer Immunology Immunotherapy, 1993-05, Vol.36 (3), p.191-197

1993

Volltextzugriff (PDF)

Immunogenicity and immunosensitivity of ex vivo human carcinomas : interferon γ and tumour necrosis factor α treatment of tumour cells potentiates their interaction with autologous blood lymphocytes

Cancer Immunology, Immunotherapy : CII, 1995-10, Vol.41 (4), p.217-226

1995

Volltextzugriff (PDF)

Diverse effect of cytokine treatment of tumor cells on specific versus non-specific cytotoxicity

Medical oncology and tumor pharmacotherapy, 1992-03, Vol.9 (1), p.25-33

1992

Volltextzugriff (PDF)

Assembly of MHC class I molecules in ex vivo carcinoma cells induced by IFN-γ or by a binding peptide

Cellular immunology, 1992-07, Vol.142 (2), p.296-302

1992

Volltextzugriff (PDF)

Cytotoxic susceptibility and defective MHC class I expression do not correlate with mutation of p53 in human carcinomas

Cancer Immunology Immunotherapy, 1994, Vol.38 (1), p.71-73

1994

Volltextzugriff (PDF)

A clinical and histologic examination in humans of the osseous response to implanted natural bone mineral

The International journal of oral and maxillofacial implants, 1997-03, Vol.12 (2), p.194

1997

Volltextzugriff (PDF)

Reconstruction of severely resorbed alveolar ridge crests with dental implants using a bovine bone mineral for augmentation

The International journal of oral and maxillofacial implants, 2001-01, Vol.16 (1), p.90

2001

Volltextzugriff (PDF)

A 1-year clinical report of a one-piece implant abutment

The International journal of prosthodontics, 2001-03, Vol.14 (2), p.159

2001

Volltextzugriff (PDF)

Addition of dimethyloxosulfonium methylide to enantiomerically pure sulfinimines: Asymmetric synthesis of 2-substituted aziridines

Tetrahedron: asymmetry, 1995-07, Vol.6 (7), p.1511-1514

1995

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)
Tagungsberichte
(2)

Sprache

Englisch
(25)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Science & Technology
(16)
Female
(15)
Life Sciences & Biomedicine
(14)
Medicin Och Hälsovetenskap
(12)
Biological And Medical Sciences
(10)
Oncology
(10)
Medical Sciences
(9)
Tumor Cells, Cultured
(8)
Tumors
(8)
Middle Aged
(7)
Aged
(6)
Immunology
(6)
Male
(6)
Ovarian Neoplasms - Immunology
(6)
Adult
(5)
Aged, 80 And Over
(5)
Host-Tumor Relations. Immunology. Biological Markers
(5)
Ovarian Neoplasms - Genetics
(5)
Carcinoma - Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective Expression of Interleukin 10, Interferon γ, and Granulocyte-Macrophage Colony-Stimulating Factor in Ovarian Cancer Biopsies

Anemia and quality of life including anemia-related symptoms in patients with solid tumors in clinical practice

Identification of New HER2/neu-Derived Peptide Epitopes That Can Elicit Specific CTL Against Autologous and Allogeneic Carcinomas and Melanomas

ASSOCIATION BETWEEN EXPRESSION OF HLA-A2 AND OVARIAN CANCER

An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital

High frequency of human leucocyte antigen (HLA) A2 reflects a poorer prognosis in a group of advanced ovarian cancer patients

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates

Mechanisms of escape from CD8+ T‐cell clones specific for the HER‐2/NEU proto‐oncogene expressed in ovarian carcinomas: Related and unrelated to decreased MHC class 1 expression

Clinical relevance of the CA 125 assay in monitoring of ovarian cancer patients

Human ex vivo carcinoma cells produce transforming growth factor β and thereby can inhibit lymphocyte functions in vitro

Molecular analysis of the retinoblastoma gene in primary ovarian cancer cells

Human leukocyte antigen (HLA) a2 as a negative prognostic factor in ovarian cancer patients

High frequency of human leucocyte antigen (HLA) A2 reflects a poorer prognosis in a group of advanced ovarian cancer patients

Mechanisms of escape from CD8+ T-cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: related and unrelated to decreased MHC class 1 expression

Mechanisms of escape from CD8 super(+) T-cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: Related and unrelated to decreased MHC class 1 expression

Interferon-gamma and tumor necrosis factor-alpha treatment of ex vivo human carcinoma cells potentiates their interaction with allogeneic lymphocytes

Restricted T cell receptor V-β and J-β usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas

Immunogenicity and immunosensitivity of ex vivo human carcinomas : interferon γ and tumour necrosis factor α treatment of tumour cells potentiates their interaction with autologous blood lymphocytes

Diverse effect of cytokine treatment of tumor cells on specific versus non-specific cytotoxicity

Assembly of MHC class I molecules in ex vivo carcinoma cells induced by IFN-γ or by a binding peptide

Cytotoxic susceptibility and defective MHC class I expression do not correlate with mutation of p53 in human carcinomas

A clinical and histologic examination in humans of the osseous response to implanted natural bone mineral

Reconstruction of severely resorbed alveolar ridge crests with dental implants using a bovine bone mineral for augmentation

A 1-year clinical report of a one-piece implant abutment

Addition of dimethyloxosulfonium methylide to enantiomerically pure sulfinimines: Asymmetric synthesis of 2-substituted aziridines

Suchergebnisse filtern